We'd like your feedback
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.
Cambridge Cancer Trials Centre, Coordination Team
01223216083
cctu.cancer@addenbrookes.nhs.uk
Early Phase Team, Cambridge Clinical Trials Unit - Cancer Theme
01223216083
cctuep@addenbrookes.nhs.uk
This information is provided directly by researchers, and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information. In some summaries, you may come across links to external websites. These websites will have more information to help you better understand the study.
A dose escalation trial to assess the safety of AZD6738 in combination with gemcitabine in participants with advanced solid tumours.
Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.
The recruitment start and end dates are as follows:
You can take part if:
You may not be able to take part if:
This is in the inclusion criteria above
Below are the locations for where you can take part in the trial. Please note that not all sites may be open.
Early Phase Team, Cambridge Clinical Trials Unit - Cancer Theme
01223216083
cctuep@addenbrookes.nhs.uk
Cambridge Cancer Trials Centre, Coordination Team
01223216083
cctu.cancer@addenbrookes.nhs.uk
The study is sponsored by CCTU- Cancer Theme and is in collaboration with AstraZeneca.
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
You can print or share the study information with your GP/healthcare provider or contact the research team directly.
